Biogen (BIIB) announced the appointment of Monish Patolawala, currently President and Chief Financial Officer of 3M Company (MMM), to the Company’s Board of Directors, effective January 1, 2024. As an accomplished financial executive, Patolawala is qualified as an Audit Committee financial expert and may be asked to serve as a member of the Board’s Audit Committee.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BIIB:
- Biogen Appoints Monish Patolawala to its Board of Directors
- Biogen Inc. (BIIB) Q3 Earnings Cheat Sheet
- Prothena price target lowered to $43 from $60 at RBC Capital
- Eisai Presents New LEQEMBI® (lecanemab-irmb) Investigational Subcutaneous Formulation Interim Study Results and Clinical Improvement Data in Earlier Stages of Early Alzheimer’s Disease From Additional Analyses of Clarity AD at The Clinical Trials On Alzheimer’s Disease (CTAD) Conference
- New Data from Biogen’s Investigational Antisense Oligonucleotide (ASO) Targeting Tau Shows Promise for Potential New Generation of Treatments in Early Alzheimer’s Disease
